Mrna Stock Forecast 2024. Buy as company anticipates 2024 launch of rsv vaccine. But odds are that in five years, covid vaccine revenue will be minimal at best for moderna.
Is it worth taking profit / loss on mrna stock now or waiting? The company just released its latest results and revenue totaled $6.8 billion.
What Are Analysts' Forecasts For Moderna Stock?.
(26.28% upside) based on 17 wall street analysts offering 12 month price targets for moderna in the last 3 months.
Moderna Has Generated ($12.41) Earnings Per Share Over The Last Year ( ($12.41) Diluted Earnings Per.
Check if this forecast comes true in a year, meanwhile.
Stock Market News, March 11, 2024:
Images References :
Stock Market News, March 11, 2024:
For 2023, mrna projects its product sales could reach at least $6b before sliding to ~$4b in 2024, ahead of a potential return to growth in 2025.
But Odds Are That In Five Years, Covid Vaccine Revenue Will Be Minimal At Best For Moderna.